Mike Russ (Genentech)

article

Progress in the implementation of biofluorescent particle counters

Despite the promise of biofluorescent particle counters (BFPCs) as an…

24 August 2022 | By Hannah Balfour (European Pharmaceutical Review)

Despite the promise of biofluorescent particle counters (BFPCs) as an alternative and rapid microbiological method and process analytical technology, their implementation thus far has predominantly occurred in non-GMP environments. In this article, EPR’s Hannah Balfour explores the reasons, with comment from Mike Russ, Senior Manager, Head of QCLS/Analytical Science and…

article

Environmental Monitoring In-Depth Focus 2022

Features in this in-depth focus explore the development of a…

24 August 2022 | By European Pharmaceutical Review

Features in this in-depth focus explore the development of a sustainable approach to bacterial endotoxin testing (BET) within a global enterprise, as well as progress towards the use of biofluorescent particle counters for water bioburden applications.

article

European Pharmaceutical Review Issue 4 2022

In EPR Issue 4, experts discuss implementing a global strategy…

24 August 2022 | By European Pharmaceutical Review

In EPR Issue 4, experts discuss implementing a global strategy to improve the sustainability of endotoxin testing, how to accelerate timelines for manufacture of multi-specific antibodies and the potential of oncolytic viruses as a therapy for glioblastoma. Also featured: progress towards smart vaccine manufacturing, an update on edible anticounterfeiting technology,…